These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 9765243

  • 1. Human procarboxypeptidase U, or thrombin-activable fibrinolysis inhibitor, is a substrate for transglutaminases. Evidence for transglutaminase-catalyzed cross-linking to fibrin.
    Valnickova Z, Enghild JJ.
    J Biol Chem; 1998 Oct 16; 273(42):27220-4. PubMed ID: 9765243
    [Abstract] [Full Text] [Related]

  • 2. Proteolytic activation of purified human procarboxypeptidase U.
    Schatteman KA, Goossens FJ, Scharpé SS, Hendriks DF.
    Clin Chim Acta; 2000 Feb 25; 292(1-2):25-40. PubMed ID: 10686274
    [Abstract] [Full Text] [Related]

  • 3. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE, Dobson JV, Greenberg CS.
    Biochim Biophys Acta; 1986 Aug 15; 872(3):261-8. PubMed ID: 2873839
    [Abstract] [Full Text] [Related]

  • 4. Contact with the N termini in the central E domain enhances the reactivities of the distal D domains of fibrin to factor XIIIa.
    Samokhin GP, Lorand L.
    J Biol Chem; 1995 Sep 15; 270(37):21827-32. PubMed ID: 7665605
    [Abstract] [Full Text] [Related]

  • 5. [Regulatory mechanism of fibrinolysis system by thrombin activatable fibrinolysis inhibitor (TAFI)].
    Urano T.
    Nihon Yakurigaku Zasshi; 2000 Nov 15; 116(5):298-303. PubMed ID: 11215380
    [Abstract] [Full Text] [Related]

  • 6. Human complement C3 is a substrate for transglutaminases. A functional link between non-protease-based members of the coagulation and complement cascades.
    Nikolajsen CL, Scavenius C, Enghild JJ.
    Biochemistry; 2012 Jun 12; 51(23):4735-42. PubMed ID: 22630814
    [Abstract] [Full Text] [Related]

  • 7. Characterization of plasmin-mediated activation of plasma procarboxypeptidase B. Modulation by glycosaminoglycans.
    Mao SS, Cooper CM, Wood T, Shafer JA, Gardell SJ.
    J Biol Chem; 1999 Dec 03; 274(49):35046-52. PubMed ID: 10574983
    [Abstract] [Full Text] [Related]

  • 8. Labeling of epsilon-lysine crosslinking sites in proteins with peptide substrates of factor XIIIa and transglutaminase.
    Parameswaran KN, Velasco PT, Wilson J, Lorand L.
    Proc Natl Acad Sci U S A; 1990 Nov 03; 87(21):8472-5. PubMed ID: 1978326
    [Abstract] [Full Text] [Related]

  • 9. Biotinylated peptides containing a factor XIIIa or a tissue transglutaminase-reactive glutaminyl residue that block protein cross-linking phenomena by becoming incorporated into amine donor sites.
    Lorand L, Parameswaran KN, Velasco PT, Murthy SN.
    Bioconjug Chem; 1992 Nov 03; 3(1):37-41. PubMed ID: 1352131
    [Abstract] [Full Text] [Related]

  • 10. Identification of factor XIIIA-reactive glutamine acceptor and lysine donor sites within fibronectin-binding protein (FnbA) from Staphylococcus aureus.
    Anderson ET, Fletcher L, Severin A, Murphy E, Baker SM, Matsuka YV.
    Biochemistry; 2004 Sep 21; 43(37):11842-52. PubMed ID: 15362870
    [Abstract] [Full Text] [Related]

  • 11. New insights into factors affecting clot stability: A role for thrombin activatable fibrinolysis inhibitor (TAFI; plasma procarboxypeptidase B, plasma procarboxypeptidase U, procarboxypeptidase R).
    Bouma BN, Meijers JC.
    Semin Hematol; 2004 Jan 21; 41(1 Suppl 1):13-9. PubMed ID: 14872415
    [Abstract] [Full Text] [Related]

  • 12. Staphylococcus aureus fibronectin-binding protein serves as a substrate for coagulation factor XIIIa: evidence for factor XIIIa-catalyzed covalent cross-linking to fibronectin and fibrin.
    Matsuka YV, Anderson ET, Milner-Fish T, Ooi P, Baker S.
    Biochemistry; 2003 Dec 16; 42(49):14643-52. PubMed ID: 14661977
    [Abstract] [Full Text] [Related]

  • 13. Plasma carboxypeptidase U (CPU, CPB2, TAFIa) generation during in vitro clot lysis and its interplay between coagulation and fibrinolysis.
    Leenaerts D, Aernouts J, Van Der Veken P, Sim Y, Lambeir AM, Hendriks D.
    Thromb Haemost; 2017 Jul 26; 117(8):1498-1508. PubMed ID: 28692110
    [Abstract] [Full Text] [Related]

  • 14. Cross-linking of alpha 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor.
    Tamaki T, Aoki N.
    J Biol Chem; 1982 Dec 25; 257(24):14767-72. PubMed ID: 6129243
    [Abstract] [Full Text] [Related]

  • 15. C1 inhibitor cross-linking by tissue transglutaminase.
    Hauert J, Patston PA, Schapira M.
    J Biol Chem; 2000 May 12; 275(19):14558-62. PubMed ID: 10799541
    [Abstract] [Full Text] [Related]

  • 16. Coagulation factor XIIIa undergoes a conformational change evoked by glutamine substrate. Studies on kinetics of inhibition and binding of XIIIA by a cross-reacting antifibrinogen antibody.
    Mitkevich OV, Shainoff JR, DiBello PM, Yee VC, Teller DC, Smejkal GB, Bishop PD, Kolotushkina IS, Fickenscher K, Samokhin GP.
    J Biol Chem; 1998 Jun 05; 273(23):14387-91. PubMed ID: 9603949
    [Abstract] [Full Text] [Related]

  • 17. Factor XIIIa-derived peptides inhibit transglutaminase activity. Localization of substrate recognition sites.
    Achyuthan KE, Slaughter TF, Santiago MA, Enghild JJ, Greenberg CS.
    J Biol Chem; 1993 Oct 05; 268(28):21284-92. PubMed ID: 8104938
    [Abstract] [Full Text] [Related]

  • 18. Human inter-α-inhibitor is a substrate for factor XIIIa and tissue transglutaminase.
    Scavenius C, Sanggaard KW, Nikolajsen CL, Bak S, Valnickova Z, Thøgersen IB, Jensen ON, Højrup P, Enghild JJ.
    Biochim Biophys Acta; 2011 Dec 05; 1814(12):1624-30. PubMed ID: 21939789
    [Abstract] [Full Text] [Related]

  • 19. A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor.
    Wang W, Boffa MB, Bajzar L, Walker JB, Nesheim ME.
    J Biol Chem; 1998 Oct 16; 273(42):27176-81. PubMed ID: 9765237
    [Abstract] [Full Text] [Related]

  • 20. Assay of procarboxypeptidase U, a novel determinant of the fibrinolytic cascade, in human plasma.
    Schatteman KA, Goossens FJ, Scharpé SS, Neels HM, Hendriks DF.
    Clin Chem; 1999 Jun 16; 45(6 Pt 1):807-13. PubMed ID: 10351989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.